Orthopedic Devices - NAFTA | Statista Market Forecast

The projected revenue in the Orthopedic Devices market market within the North American Free Trade Agreement (in North American Free Trade Agreement (NAFTA)) is expected to reach US$17.81bn by the year 2024.
This market is anticipated to display a Compound Annual Growth Rate (CAGR) of 3.62% between 2024 and 2029, leading to a market volume of US$21.28bn by the end of 2029.
It is worth noting that, in comparison to other global markets, the United States is expected to generate the highest revenue, amounting to US$16.02bn in 2024.
In NAFTA, the orthopedic devices market is experiencing a surge in demand due to the aging population and increasing prevalence of chronic musculoskeletal conditions.

Definition:
The Orthopedic Devices market contains medical equipment and accessories used to treat orthopedic disorders, including joint reconstruction, spinal devices, trauma fixation devices, arthroscopic devices, etc.

Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B) as well as governments (B2G). Revenues are allocated to the country where the money is spent.

Company examples: Johnson & Johnson, Zimmer Biomet, Stryker, Medtronic. Further information on the key players can be found in the Market Shares boxes.

Joint reconstruction implants
Spinal devices
Trauma fixation devices
Arthroscopy devices

Orthopedic pharmaceuticals
Orthopedic supplements

The Orthopedic Devices market in NAFTA is experiencing significant growth due to several factors. Customer preferences for advanced and innovative orthopedic devices, increasing prevalence of orthopedic conditions, and the presence of local special circumstances are driving this market trend. Additionally, underlying macroeconomic factors such as the rising healthcare expenditure and the aging population are also contributing to the development of the Orthopedic Devices market in NAFTA. Customer preferences play a crucial role in shaping the Orthopedic Devices market in NAFTA. Patients and healthcare professionals are increasingly demanding advanced orthopedic devices that offer better outcomes and faster recovery times. This has led to the development of innovative technologies such as minimally invasive surgeries, 3D printing, and robotic-assisted surgeries. These advancements not only improve patient outcomes but also reduce healthcare costs by minimizing hospital stays and post-operative complications. Trends in the market indicate a growing prevalence of orthopedic conditions in the NAFTA region. Factors such as sedentary lifestyles, obesity, and an aging population contribute to the increasing incidence of orthopedic conditions such as osteoarthritis, fractures, and musculoskeletal disorders. As a result, there is a rising demand for orthopedic devices such as joint replacements, spinal implants, and trauma fixation devices. This trend is expected to continue as the population ages and the prevalence of chronic diseases increases. Local special circumstances in the NAFTA region also impact the Orthopedic Devices market. The presence of well-established healthcare infrastructure and reimbursement systems in countries like the United States and Canada facilitates access to orthopedic devices for patients. Additionally, the presence of leading orthopedic device manufacturers in the region further drives market growth. These companies invest heavily in research and development to introduce new and innovative products, which in turn, stimulates market demand. Underlying macroeconomic factors also contribute to the development of the Orthopedic Devices market in NAFTA. Rising healthcare expenditure, driven by increasing healthcare costs and government initiatives to improve healthcare infrastructure, provides a favorable environment for market growth. Furthermore, the aging population in the region, coupled with the increasing prevalence of chronic diseases, creates a significant market opportunity for orthopedic device manufacturers. In conclusion, the Orthopedic Devices market in NAFTA is experiencing growth due to customer preferences for advanced and innovative devices, increasing prevalence of orthopedic conditions, and the presence of local special circumstances. Additionally, underlying macroeconomic factors such as rising healthcare expenditure and the aging population also contribute to market development. As the demand for orthopedic devices continues to rise, manufacturers and healthcare providers in the region will need to adapt to these trends to meet the needs of patients and capitalize on market opportunities.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.